NSGO_org
23 posts
NSGO_org
@nsgo_org
The Nordic Society of Gynaecological Oncology & Cinical Trial Unit
Katılım Aralık 2022
68 Takip Edilen110 Takipçiler
🌟 Dr. Kristina Lindemann presents TIP for #PEACE 🌟 Investigating #palliation in #gynecologic #oncology, this research aims to improve patient-centered care for women battling gynecologic cancers. #ASCO2023 #GynecologicOncology
#NSGOCTUPEACE
nsgo.org/peace-tip-asco…
English
🔬🌟 #ASCO2023 Highlights: NSGO-CTU shines bright! Dr. Mansoor Raza #Mirza and Dr. Kristina Lindemann present groundbreaking work in gynecologic oncology. #ResearchBreakthroughs #GynecologicOncology #NSGO
See the TIP on NSGO.org: lnkd.in/erB-FRVn
English
English
The clinical relevance of excisional margins after large loop excision of the transformation zone for the persistence of cervical dysplasia obgyn.onlinelibrary.wiley.com/doi/10.1002/ij… @OncoAlert @nsgo_org
English
Exciting news! Dr. Mirza presented groundbreaking research on PROs in endometrial cancer patients at #ASCO2023. The study highlights the benefits of dostarlimab plus CP, improving quality of life. Congratulations to the research team! #endometrialcancer #oncology #NSGO #Mirza
English
Join The #NSGO Annual Meeting 2023 in Reykjavik June 14 - 16!
The event features presentations from renowned speakers on various topics, including the latest updates in #clinicaltrials, #surgery, and #radiationtherapy
#NSGO2023 #GynecologicalOncology #Reykjavik #ClinicalTrials
English
Dr. Mirza shared his knowledge on the latest advancements in #EndometrialCancer at The 12th International #Charité Mayo Conference 2023 in Berlin last week while connecting with friends, colleagues, and associates.
#CharitéMayoConference #CancerResearch #DrMirza #NSGOCTU #NOGGO
English
Prospective evaluation of the tolerability and efficacy of #niraparib dosing based on baseline body weight and platelet count: 𝐑𝐞𝐬𝐮𝐥𝐭𝐬 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 #𝐏𝐑𝐈𝐌𝐀/#𝐄𝐍𝐆𝐎𝐓-𝐎𝐕26/#𝐆𝐎𝐆-3012 #𝐭𝐫𝐢𝐚𝐥 pubmed.ncbi.nlm.nih.gov/37060236/
English
We had the opportunity to welcome the Nordic team from #AstraZeneca at our office in Copenhagen to exchange insights, ideas, & updates on ongoing trials. Thank you CTU 𝐏𝐫𝐨𝐣𝐞𝐜𝐭 𝐌𝐚𝐧𝐚𝐠𝐞𝐫𝐬📷 #Rigshospitalet #GynaecologicalOncology #ClinicalTrials #HealthcareInnovation
English
Interview with @MirzaCPH on the management of #ovariancancer is already available online! Check it out! 📺
@ESGO_society @ENYGO_official #NSGO
@IJGConline @IJGCfellows @pedroramirezMD @Joanna86992517
European Network of Young Gynae Oncologists@ENYGO_official
In this interview Prof. Mansoor Raza Mirza and @Joanna86992517 discuss about major achievements in the management of #ovariancancer buff.ly/3zpjqFN Full-text with all interviews: buff.ly/3XrZA6B Video recording and edit by @esragbilir @ESGO_society @IJGConline
English
Join us in #Iceland!🇮🇸
#NSGO ANNUAL MEETING 2023
-> Registration Is Open Until June 8th, 2023
@DrLB @MirzaCPH @agz_eriksson @DrZoiaRazumova @BjerreTrent
@ESGO_society @ENYGO_official
#NSGO2023
nsgo.org/am23-general-i…
English
𝐄𝐍𝐆𝐎𝐓, 𝐍𝐒𝐆𝐎-𝐂𝐓𝐔 & 𝐆𝐎𝐆 𝐩𝐫𝐨𝐮𝐝𝐥𝐲 𝐚𝐧𝐧𝐨𝐮𝐧𝐜𝐞 𝐭𝐡𝐞 𝐠𝐫𝐨𝐮𝐧𝐝-𝐛𝐫𝐞𝐚𝐤𝐢𝐧𝐠 𝐫𝐞𝐬𝐮𝐥𝐭𝐬 𝐨𝐟 𝐄𝐍𝐆𝐎𝐓-𝐄𝐍6-𝐍𝐒𝐆𝐎/𝐆𝐎𝐆-3031/𝐑𝐔𝐁𝐘 𝐭𝐫𝐢𝐚𝐥.
rb.gy/sqxq7u
#Endometrial #Cancer #RUBY #NSGO #ENGOT #Dostarlimab #ESMO #SGO
English
We're very excited about the data that our Medical Director, Mansoor Raza Mirza, will present at the #ESMOVirtualPlenary Monday March 27th about the #RUBYTrial
#NSGOCTU #NSGO #ENGOT #ESMO #EndometrialCancer
ESMO - Eur. Oncology@myESMO
#ESMOVirtualPlenary: Do patients with advanced #endometrialcancer benefit from the addition of dostarlimab to first-line platinum-based #chemotherapy? ⏰ Join us for the first session - 27 March at 18:30 CEST ow.ly/2AQh50NiBO3 #MedOnc #MedEd #MedTwitter #GynCSM @AACR
English
NSGO_org retweetledi
#ESMOVirtualPlenary: Do patients with advanced #endometrialcancer benefit from the addition of dostarlimab to first-line platinum-based #chemotherapy?
⏰ Join us for the first session - 27 March at 18:30 CEST
ow.ly/2AQh50NiBO3
#MedOnc #MedEd #MedTwitter #GynCSM @AACR
English
#NSGO-CTU will collaborate with #Kancera in our upcoming ovarian cancer study -a combined phase Ib/IIa!
shorturl.at/txCH4
English
An interim analysis of the key secondary endpoint showed a median OS of 46.3 months for patients receiving #niraparib vs 43.4 months for patients receiving placebo(HR 0.82, 95% CI 0.56-1.20) in the ITT population - #MansoorRazaMirza, #Rigshospitalet. shorturl.at/dfL58 #NSGO
English
#ESMO Virtual Plenary - Dr. Mansoor Raza Mirza will give a live talk on results from the NORA trial on Dec. 15th at 18.30 – 19.30 CET.
esmo.org/meeting-calend…
#NORAtrial #ESMO #Gynaeological #Oncology #GSK #NSGO
English
#NSGO is dedicated to the development of new clinical trials and fostering research studies.
Visit tinyurl.com/NSGO-CTU to find the guidelines & Concept Development Form, which is used for submitting new study proposals to NSGO.
#clinicaltrials #research #development #study
English